Bayer Cropscience (Large Cap) Share Target 2025, 2026 To 2035
|
Bayer CropScience Limited |
|||
|
Price: ₹5,106.30 (-0.61%) | ||
| 52 Week Low: ₹4,901.20 52 Week High: ₹7,196.85 |
|||
| Market Capital: 25,478.07 Crore (Largecap) | |||
| Basic Materials -> Agricultural Inputs | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Bayer Cropscience Share Price Target For 2025
- 1.1.1: Bayer Cropscience Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Bayer Cropscience Share Price Target For 2026
- 1.2.1: Bayer Cropscience Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Bayer Cropscience Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Bayer Cropscience Brief Company Overview
- 4: Bayer Cropscience Financial Performance
- 4.0.1: Is Bayer Cropscience A Good Buy For Long Term?
Bayer Cropscience, a Large Cap company in the Agricultural Inputs Industry has delivered 23.6% returns in 5-year with 13.3% profit margin.
To predict the Bayer Cropscience's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Bayer Cropscience Share Price Target For 2025
The line chart displays the monthly closing prices of Bayer Cropscience with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bayer Cropscience shares in 2025, see the table below.
Bayer Cropscience Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 5562.6 (+8.93%) | Price Action: Sep 2020 Low |
| 2025 Target 2 | 5505.0 (+7.8%) | Price Action: 25 Apr 2024 Low |
| 2025 Target 1 | 5450.0 (+6.73%) | Price Action: May 2022 High |
| Current Price | 5106.30 | Bayer Cropscience's share price as of 17 Jan 2025 |
| Stop Loss 1 | 4949.0 (-3.09%) | Price Action: May 2024 Low |
| Stop Loss 2 | 4854.25 (-4.94%) | Price Action: Nov 2023 Low |
| Stop Loss 3 | 4800.0 (-6%) | Price Action: Jun 2018 High |
Short-Term Technical Outlook
Current Technical Position: Bayer Cropscience is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹5595.4 serves as the nearest technical reference point.
Historical Returns: 3-month: -22.93% | 6-month: -26.6% | 1-year: -14.92%
Bayer Cropscience Share Price Target For 2026
The line chart displays the monthly closing prices of Bayer Cropscience with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bayer Cropscience shares in 2026, see the table below.
Bayer Cropscience Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 7333.59 (+43.61%) | Price Action: Chart |
| 2026 Target 2 | 7196.85 (+40.94%) | Fibonacci Extension Level 100.00% |
| 2026 Target 1 | 7103.7 (+39.11%) | Price Action: 31 Jul 2024 High |
| Current Price | 5106.30 | Bayer Cropscience's share price as of 17 Jan 2025 |
| Stop Loss 1 | 4604.1 (-9.84%) | Price Action: Dec 2021 Low |
| Stop Loss 2 | 4544.9 (-11%) | Price Action: Mar 2020 High |
| Stop Loss 3 | 4499.0 (-11.9%) | Price Action: Dec 2017 High |
Long-Term Technical Outlook
52-Week Range Analysis: Bayer Cropscience is currently trading near its 52-week low of ₹4901.2, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -14.92% | 3-year: -1.07% | 5-year: +23.64%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Bayer Cropscience Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹5,106.30 | ||
| 2025 | ₹7,005.95 | +37.2% | ₹7,111.04 |
| 2026 | ₹7,576.64 | +8.14% | ₹7,690.29 |
| 2027 | ₹8,570.66 | +13.11% | ₹8,699.22 |
| 2028 | ₹10,145.55 | +18.37% | ₹10,297.73 |
| 2029 | ₹10,735.69 | +5.81% | ₹10,896.73 |
| 2030 | ₹11,198.38 | +4.3% | ₹11,366.36 |
| 2031 | ₹12,124.09 | +8.26% | ₹12,305.95 |
| 2032 | ₹13,933.84 | +14.92% | ₹14,142.85 |
| 2033 | ₹15,586.72 | +11.86% | ₹15,820.52 |
| 2034 | ₹17,439.60 | +11.88% | ₹17,701.19 |
| 2035 | ₹18,874.90 | +8.23% | ₹19,158.02 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Bayer Cropscience Brief Company Overview
Bayer CropScience Limited: A Leading Global Agrochemical and Pharmaceutical Company Established in 1863, Bayer CropScience Limited is a renowned manufacturer and marketer of a vast range of agrochemical products, including insecticides, fungicides, and herbicides. ...
Key Products and Services: Agrochemicals and corn seeds Pharmaceuticals in areas like cardiology, gynecology, and oncology Diagnostic imaging equipment and contrast agents Consumer health products Hybrid seeds, including corn and paddy Digital farming solutions like drones and IoT sensors Global Presence: Bayer CropScience Limited operates in India, Germany, Bangladesh, and several other countries worldwide. Commitment to Innovation: The company emphasizes its commitment to research and development, employing advanced technologies to enhance crop growth and management.Bayer Cropscience Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 25,478.07 Crore | Market valuation of Bayer Cropscience's shares. |
| Revenue (TTM) | 4,994.8 Crore | Total revenue generated by Bayer Cropscience over the past twelve months. |
| Net Income (TTM) | +666.2 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +17.93% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +13.33% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-6.2% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-22.6% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
1.65 | Company's total debt divided by total shareholder equity. |
| Total Debt | 47.1 Crore | Sum of Bayer Cropscience's current & long-term financial obligations. |
| Total Cash | 1,210.69 Crore | Total amount of liquid funds available to Bayer Cropscience. |
| Beta | 0.37 | Beta is less than 1 indicating that the Bayer Cropscience's price is less volatile than the market. |
Is Bayer Cropscience A Good Buy For Long Term?
Bayer Cropscience, a large-cap stock with a market capitalization of ₹25,478.07 crore, presents a mixed picture for long-term investors. While its ₹666.2 crore net profit (13.33% margin) on ₹4,994.8 crore revenue in the last 12 months (TTM) is positive, a concerning -22.6% year-on-year earnings decline and -6.2% sequential revenue drop warrant caution. Although boasting a strong 5-year return of 36.03%, the recent past 3-month return of -17.53% suggests current market volatility. Considering these factors, it's currently an average buy, requiring further analysis before committing to a long-term investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
